We have observed
7 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after October 11, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
CRYSTALLINE FORMS OF 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE SODIUM SALT AND THEIR MEDICAL USE
Low molecular weight immune-modulators as adjuvants for specific immunotherapy
Composition with cooling effect for topical application
PARALLEL ROLL SUBSTANCE FOR EXACT ADAPTATION OF FITTING STRIPS FOR BUILT-IN FURNITURE
PROCESS FOR THE PRODUCTION OF DRUG FORMULATIONS FOR ORAL ADMINISTRATION
Highly soluble L-DOPA glycerol esters